Know Cancer

forgot password

Prospective Clinical Study for Early Recovery After Gastric Cancer Surgery

Phase 2
65 Years
Open (Enrolling)
Fasting, Malignant Neoplasm of Stomach

Thank you

Trial Information

Prospective Clinical Study for Early Recovery After Gastric Cancer Surgery

Enrollment of patients

- Before the patients are enrolled in this study, they give us informed consents.

- A liquid diet is supplied beginning from the morning of the day prior to operation to
the midnight.

Operation and postoperative management

- All procedures are approached by laparoscopic surgery, and partial gastrectomy with
lymph node dissection are performed.

- The patients who are considered to be difficult to progress early oral feeding in
surgical field are excluded from the study.

- Nasogastric tube is not applied to patients.

- Postoperative pain is managed by non-opioid pain killer.

- The patients are started on sips of water on the first postoperative day.

- If they are tolerable, a liquid diet is started on the second postoperative day, and a
soft diet on a third postoperative day for them.

- We have a plan to discharge the patients on the fourth postoperative day if they
exhibit at least three times soft diet without specific complaint and had normal
clinical status and physical examination.

Evaluation of patients

- The patients are followed up to 30 days after discharge from hospital, and we check
whether they are tolerable without any compliant and are readmitted.

Inclusion Criteria:

- Patients who are diagnosed with gastric adenocarcinoma

- 65 years old and blew

- Patients are expected to be undergone distal subtotal gastrectomy

- No complication by gastric cancer

- No synchronous metastatic lesions

- Laparoscopic or robotic surgery

- Informed consent

Exclusion Criteria:

- Previous gastrectomy history

- Combined surgery due to synchronous malignancy

- Patients with major organ dysfunction

Type of Study:


Study Design:

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Drop rate from critical pathway

Outcome Description:

It is defined as the proportion of dropped patients from 4 days critical pathway

Outcome Time Frame:

4 days

Safety Issue:


Principal Investigator

Hoon Hur, Prof.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Ajou University School of Medicine


Korea: Institutional Review Board

Study ID:




Start Date:

July 2012

Completion Date:

August 2014

Related Keywords:

  • Fasting
  • Malignant Neoplasm of Stomach
  • Gastric cancer surgery
  • Early oral feeding
  • Fast track surgery
  • Neoplasms
  • Stomach Neoplasms